Global Biotech Oncology Partnership
How CSI supplied large quantities of ruxolitinib to a biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67...
Global Biotech Oncology Partnership
Rapid Oncology Study Supply
Diabetes Awareness
The Evolution of Biologics and Biosimilars
How to overcome drug shortages in the clinical trial supply chain
CSI becomes EcoVadis Certified
CSI is attending OCT Barcelona 2023
CSI is attending COG New England 2023
CSI is attending Clinical Trial Supply Europe 2023
The Top Five trends for the pharmaceutical industry in 2023
CSI is attending the 2023 Clinical Outsourcing Group conference UK